Weight Watchers has outlasted diet fads, rebrands and even logic. But this time, it’s not carbs or keto that brought it down ...

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...

Five scientists won this year’s Breakthrough Prize in Life Sciences for their work on GLP-1 and the development of drugs for diabetes and obesity.

WeightWatchers faces bankruptcy with £1.25 billion ($1.6 billion) in debt, losing clients to drugs like Ozempic. Can the ...

Though it could have lots of use cases in the future, Phytogene's first order of business is synthesizing glucagon-like peptide-1 (GLP-1 ... incorporate any peptide sequence into the plant ...

Weight Watchers is preparing to file for bankruptcy amid rising competition from weight-loss drugs. Get all the info and what ...

WeightWatchers has plans to file for bankruptcy in the coming months, a source familiar with the matter said on Wednesday.

Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by ...

Pharmaceutical companies like Novo Nordisk and Eli Lilly took the world by storm last year with a new generation of so-called GLP-1 diet products ... platform Sequence, now known as ...

Sequence, a telehealth platform providing access to GLP-1 weight-loss medications, was purchased to integrate prescription weight-loss solutions into WeightWatchers' existing programmes ...